Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$4.01+0.12 (+3.08%)
Close on Nov 12, 2026Market cap $195.19MP/E –Yield –
Nu Skin Enterprises EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Nu Skin Enterprises's EV/EBITDA was 5.5× on Nov 11, 2026, against 10.4× a year earlier. Over the last 5 years it ranged from 2.2× to 13.0×, with a median of 8.1×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.5× | −4.6 |
| 2025 | Dec 31, 2025 | 10.1× | +2.9 |
| 2024 | Jul 31, 2024 | 7.2× | −2.1 |
| 2023 | Dec 29, 2023 | 9.4× | −3.5 |
| 2022 | Dec 30, 2022 | 12.8× | +5.6 |
| 2021 | Dec 31, 2021 | 7.2× | −2.6 |
| 2020 | Dec 31, 2020 | 9.8× | +2.2 |
| 2019 | Dec 31, 2019 | 7.6× | −1.1 |
| 2018 | Dec 31, 2018 | 8.7× | −3.6 |
| 2017 | Dec 29, 2017 | 12.3× | +3.7 |
| 2016 | Dec 30, 2016 | 8.6× | +2.2 |
| 2015 | Dec 31, 2015 | 6.4× | +1.9 |
| 2014 | Dec 31, 2014 | 4.5× | −3.6 |
| 2013 | Apr 30, 2013 | 8.2× | −1.9 |
| 2012 | Jul 31, 2012 | 10.0× | −1.8 |
| 2011 | Dec 30, 2011 | 11.9× | −5.5 |
| 2010 | Dec 31, 2010 | 17.4× | +7.1 |
| 2009 | Dec 31, 2009 | 10.3× | – |
See a number that looks wrong?